MASK (Mobile Airways Sentinel Network), nell’ambito dell’iniziativa Allergic Rhinitis and its Impact on Asthma (ARIA), coinvolge oltre 22 Paesi a livello mondiale. Lavora a stretto contatto con POLLAR (Impact of Air POLLution on Asthma and Rhinitis, EIT Health) e collabora con organizzazioni professionali e di pazienti nel campo delle allergie e delle malattie delle vie respiratorie.

MASK propone percorsi di cura reali incentrati sul paziente con rinite e/o asma multimorbilità.

Il CIRFF partecipa attivamente al gruppo di lavoro ARIA in the PHARMACY, il quale mira a sviluppare e studiare l’utilizzo di dispositivi digitali per le malattie respiratorie nel setting della farmacia di comunità.

Risultati disponibili:

• Management of allergic rhinitis symptoms in the pharmacy Pocket guide 2022. Clinical and Translational Allergy

• Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: The ARIA-MASK-air^® approach. Clinical and Translational Allergy

• Active and Healthy Living in the Digital World. Futurium

• 2019 ARIA Care pathways for allergen immunotherapy. European Academy of Allergy and Clinical Immunology

• ARIA pharmacy 2018 “Allergic rhinitis care pathways for community pharmacy”. European Academy of Allergy and Clinical Immunology

• Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma. Clinical and Translational Allergy

• Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology. Journal of Allergy and Clinical Immunology

• MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence. Clinical and Translational Allergy

• Treatment of allergic rhinitis using mobile technology with real‐world data: The MASK observational pilot study. Journal of Allergy and Clinical Immunology

• The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study. Journal of Allergy and Clinical Immunology